Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis

Respiration

Volumn 91, Issue 6, 2016, Pages 497-502

  Bahmer, Thomas ^a,d   Kirsten, Anne Marie ^b,d   Waschki, Benjamin ^a,d   Rabe, Klaus F ^a,d   Magnussen, Helgo ^b,d   Kirsten, Detlef ^a,d   Gramm, Marco ^b,d   Hummler, Simone ^c,d   Brunnemer, Eva ^c,d   Kreuter, Michael ^c,d   Watz, Henrik ^b,d  

^a LungClinic Grosshansdorf   (Germany)

^b Pulmonary Research Institute   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d German Center for Lung Research (DZL)   (Germany)

Author keywords

Exercise capacity; Fatigue; Idiopathic interstitial pneumonia; Idiopathic pulmonary fibrosis; Physical activity

Indexed keywords

6 MINUTE WALK TEST; ACCELEROMETRY; AGED; ARTICLE; CLINICAL ARTICLE; DIFFUSING CAPACITY FOR CARBON MONOXIDE; DISEASE ASSOCIATION; DYSPNEA; EXERCISE; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FATIGUE; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; FUNCTIONAL STATUS ASSESSMENT; GERMANY; HUMAN; LUNG FUNCTION; MALE; MODIFIED MEDICAL RESEARCH COUNCIL; MULTIDIMENSIONAL FATIGUE INVENTORY; OXYGEN THERAPY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE ASSESSMENT; RESPIRATORY TRACT PARAMETERS; SHORT FORM 12; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOM; COMPLICATION; EXERCISE TOLERANCE; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; DYSPNEA; EXERCISE; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS;

EID: 84979009811     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000446607     Document Type: Article

References (23)

1. Raghu G, Collard HR, Egan JJ, et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
2. Nathan SD, du Bois RM, Albera C, et al: Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis. Respir Med 2015; 109: 914-922.
3. du Bois RM, Albera C, Bradford WZ, et al: 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J 2014; 43: 1421-1429.
4. Weir NA, Brown AW, Shlobin OA, et al: The influence of alternative instruction on 6-min walk test distance. Chest 2013; 144: 1900-1905.
5. Waschki B, Kirsten A, Holz O, et al: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140: 331-342.
6. Nakayama M, Bando M, Araki K, et al: Physical activity in patients with idiopathic pulmonary fibrosis. Respirology 2015; 20: 640-646.
7. Wallaert B, Monge E, Le Rouzic O, et al: Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013; 144: 1652-1658.
8. Langer D, Cebria i Iranzo MA, Burtin C, et al: Determinants of physical activity in daily life in candidates for lung transplantation. Respir Med 2012; 106: 747-754.
9. Swigris JJ, Kuschner WG, Jacobs SS, et al: Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005; 60: 588-594.
10. Swigris JJ, Brown KK, Behr J, et al: The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 2010; 104: 296-304.
11. De Vries J, Seebregts A, Drent M: Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used? Respir Med 2000; 94: 273-278.
12. Milioli G, Bosi M, Poletti V, et al: Sleep and respiratory sleep disorders in idiopathic pulmonary fibrosis. Sleep Med Rev 2015; 26: 57-63.
13. Mermigkis C, Stagaki E, Amfilochiou A, et al: Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. Med Princ Pract 2009; 18: 10-15.
14. Watz H, Waschki B, Meyer T, et al: Physical activity in patients with COPD. Eur Respir J 2009; 33: 262-272.
15. Macintyre N, Crapo RO, Viegi G, et al: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
16. Wanger J, Clausen JL, Coates A, et al: Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522.
17. Miller MR, Hankinson J, Brusasco V, et al: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
18. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
19. Nishiyama O, Taniguchi H, Kondoh Y, et al: A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J 2010; 36: 1067-1072.
20. Lin JM, Brimmer DJ, Maloney EM, et al: Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr 2009; 7: 18.
21. Han MK, Swigris J, Liu L, et al: Gender influences health-related quality of life in IPF. Respir Med 2010; 104: 724-730.
22. Swigris JJ, Esser D, Conoscenti CS, et al: The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health Qual Life Outcomes 2014; 12: 124.
23. Schwarz R, Krauss O, Hinz A: Fatigue in the general population. Onkologie 2003; 26: 140-144.